The two best pre-earnings setups in the morning scan - the ticker, the entry price, the targets and the stop-loss - in your inbox right after the open.
Healthcare, Diagnostics & Research
Next earnings date for MTD: February 04, 2027 Last price $1718.71. Analyst mean target $1737 from 12 analysts, consensus Hold.
February 04, 2027. That is the date the AI Market Cap scanner has for MTD, and it moves as the company confirms it.
12 analysts cover MTD is Hold, and the mean target is $1737 against a last price of $1718.71.
MTD is in the Healthcare sector, in the Diagnostics & Research industry; its market cap is $34.2B; its trailing P/E is 37.3.
Pre-earnings entry zone, analyst PE target, 3-day and 5-day implied move, and stop loss — all unlocked with a $29/month subscription.
Unlock Full Analysis →Mettler-Toledo International trades on NASDAQ under the ticker MTD. The company operates in the Healthcare sector — specifically Diagnostics & Research.
Current analyst consensus rating: Hold with a $1737 price target based on 12 analyst opinions.
EPS (trailing): $46.07 | Market Cap: $34.2B
Healthcare Diagnostics & Research
Trading stocks before earnings requires understanding three key variables: the implied move (what the options market expects), the historical beat rate for the sector, and the current momentum leading into the report.
For MTD, the next earnings report is scheduled for February 04, 2027.
The implied move is calculated using at-the-money straddles — if the straddle is priced at X%, the market is pricing in approximately a ±X% move in either direction around the earnings release.
Our pre-earnings momentum scanner scores MTD across five factors to identify high-conviction setups:
The Pro subscription shows the full target range, stop loss, and implied move for MTD and all 20+ stocks in the current earnings window.